International Stem Cell ISCO
OTC ISCO
$0.47 -0.07 (-12.96%)
As of: Aug 21, 2026 · 2:44 PM EDT

International Stem Cell (ISCO) Amortizatization of Intangibles (2019)

International Stem Cell (ISCO) posted quarterly Amortizatization of Intangibles of $18000.0 for Q1 2019.

International Stem Cell (ISCO) Amortizatization of Intangibles (2019) Analysis & Trends

International Stem Cell (ISCO) has reported Amortizatization of Intangibles for 1 consecutive years, with $18000.0 the latest figure, recorded in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 International Stem Cell 3.76 Mn 2.67 Mn 1.46 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2019 18,000.00
Mar 31, 2019 18,000.00